首页> 外文期刊>Molecular biology of the cell >A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase
【24h】

A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase

机译:通过14-3-3与肌球蛋白磷酸酶结合的一种新的肌球蛋白轻链磷酸化调节机制

获取原文
获取原文并翻译 | 示例
           

摘要

Myosin II phosphorylation-dependent cell motile events are regulated by myosin light-chain (MLC) kinase and MLC phosphatase (MLCP). Recent studies have revealed myosin phosphatase targeting subunit (MYPT1), a myosin-binding subunit of MLCP, plays a critical role in MLCP regulation. Here we report the new regulatory mechanism of MLCP via the interaction between 14-3-3 and MYPT1. The binding of 14-3-3 beta to MYPT1 diminished the direct binding between MYPT1 and myosin II, and 14-3-3 beta overexpression abolished MYPT1 localization at stress fiber. Furthermore, 14-3-3 beta inhibited MLCP holoenzyme activity via the interaction with MYPT1. Consistently, 14-3-3 beta overexpression increased myosin II phosphorylation in cells. We found that MYPT1 phosphorylation at Ser472 was critical for the binding to 14-3-3. Epidermal growth factor (EGF) stimulation increased both Ser472 phosphorylation and the binding of MYPT1-14-3-3. Rho-kinase inhibitor inhibited the EGF-induced Ser472 phosphorylation and the binding of MYPT1-14-3-3. Rho-kinase specific siRNA also decreased EGF-induced Ser472 phosphorylation correlated with the decrease in MLC phosphorylation. The present study revealed a new RhoA/Rho-kinase-dependent regulatory mechanism of myosin II phosphorylation by 14-3-3 that dissociates MLCP from myosin II and attenuates MLCP activity.
机译:肌球蛋白II磷酸化依赖的细胞运动事件受肌球蛋白轻链(MLC)激酶和MLC磷酸酶(MLCP)调控。最近的研究表明,肌球蛋白磷酸酶靶向亚基(MYPT1)是MLCP的肌球蛋白结合亚基,在MLCP调节中起关键作用。在这里,我们通过14-3-3和MYPT1之间的相互作用报告了MLCP的新调节机制。 14-3-3 beta与MYPT1的结合减少了MYPT1和肌球蛋白II之间的直接结合,并且14-3-3 beta过表达消除了MYPT1在应力纤维上的定位。此外,14-3-3 beta通过与MYPT1的相互作用抑制了MLCP全酶的活性。一致地,14-3-3β过表达增加了细胞中肌球蛋白II的磷酸化。我们发现,Ser472的MYPT1磷酸化对于与14-3-3的结合至关重要。表皮生长因子(EGF)刺激增加了Ser472磷酸化和MYPT1-14-3-3的结合。 Rho激酶抑制剂抑制EGF诱导的Ser472磷酸化和MYPT1-14-3-3的结合。 Rho激酶特异性siRNA也减少了EGF诱导的Ser472磷酸化,这与MLC磷酸化的减少有关。本研究揭示了一种新的RhoA / Rho激酶依赖性的肌球蛋白II的14-3-3磷酸化调节机制,可将MLCP与肌球蛋白II分离并减弱MLCP活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号